Danaher Corporation (DHR)
NYSE · Healthcare · Diagnostics & Research
Danaher Corporation is a Healthcare company with a market capitalization of $140.31B, a trailing P/E ratio of 35.6, and a dividend yield of 0.51%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | July 21, 2026 | $1.94 | $1.84 | +5.4% |
| Q1 2026 | April 21, 2026 | $2.06 | $1.94 | +6.2% |
| Q4 2025 | January 28, 2026 | $2.23 | $2.19 | +1.8% |
| Q3 2025 | October 21, 2025 | $1.89 | $1.72 | +9.9% |
| Q2 2025 | July 22, 2025 | $1.80 | $1.64 | +9.8% |
| Q1 2025 | April 22, 2025 | $1.88 | $1.64 | +14.6% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 10,096,457 | 1.42% | 2.7 | -7.0% |
| June 30, 2026 | 10,858,205 | 1.53% | 2.4 | -5.5% |
| June 15, 2026 | 11,493,085 | 1.62% | 2.9 | +23.7% |
| May 29, 2026 | 9,289,510 | 1.31% | 2.0 | +10.6% |
| May 15, 2026 | 8,397,302 | 1.18% | 1.7 | -2.2% |
| April 30, 2026 | 8,585,579 | 1.21% | 1.5 | +5.0% |
| April 15, 2026 | 8,176,911 | 1.15% | 2.6 | +17.8% |
| March 31, 2026 | 6,939,368 | 0.98% | 1.6 | +25.0% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Danaher Corporation's market cap?
As of August 13, 2026, Danaher Corporation (DHR) has a market capitalization of $140.31B.
What is Danaher Corporation's P/E ratio?
Danaher Corporation trades at a trailing price-to-earnings (P/E) ratio of 35.6. Its forward P/E is 23.4.
Does Danaher Corporation pay a dividend?
Yes — Danaher Corporation pays a dividend yielding 0.51%, an annual payout of $1.44 per share.
What sector is DHR in?
Danaher Corporation is in the Healthcare sector, specifically the Diagnostics & Research industry.
What is Danaher Corporation's short interest?
As of the July 15, 2026 FINRA settlement, 10,096,457 DHR shares were sold short, or 1.42% of shares outstanding. Days to cover: 2.7. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Danaher Corporation's revenue?
In its latest reported fiscal year (ending December 31, 2025), Danaher Corporation reported revenue of $24.57B and net income of $3.61B.
Ask your own questions about DHR
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.